Skip to main content
. 2016 Sep 12;5(2):147–159. doi: 10.1007/s40123-016-0062-6

Table 2.

Reported factors associated with successful pharmacologic vitreomacular traction (VMT) release with ocriplasmin (0.125 mg)

Phakic status
Age younger than 65 years
Small adhesion diameter (≤1500 μm)
Presence of full thickness macular hole
Absence of epiretinal membrane
Absence of concurrent retinal disease
Shorter duration of VMT
Transient outer retinal layer abnormalities on OCT
Macular hole size <250 μm
Macular hole ‘width factor’18 (basal diameter–minimum linear diameter) <60 μm